Luigi Zattera

Luigi Zattera

Auto-generated profile, based on publicly available information

Luigi Zattera

Neurointensive Care Unit, Department of Anesthesiology and Critical Care, Hospital Clínic de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
CFCarlos Ferrando
Carlos Ferrando
JVJordi Vallverdú
Jordi Vallverdú
LZLuigi Zattera
Luigi Zattera
GTGerardo Tusman
Gerardo Tusman
FSFernando Suárez-Sipmann
Fernando Suárez-Sipmann

1 September 2025 in Stroke
Verified
Journal Article
Closed access
LLLaura Llull
Laura Llull
DSDaniel Santana
Daniel Santana
AMAlejandra Mosteiro
Alejandra Mosteiro
LPLeire Pedrosa
Leire Pedrosa
CLCarlos Laredo
Carlos Laredo
SASergio Amaro
Sergio Amaro
BACKGROUND: Spontaneous aneurysmal subarachnoid hemorrhage induces early blood-brain barrier permeability dysfunction, although its clinical relevance and underlying mechanisms remain poorly understood. We aimed to evaluate the association between blood-brain barrier disruption, quantified with dynamic contrast–enhanced magnetic resonance imaging at the end of the early brain injury period, circulating neuroinflammatory mediators, and long-term clinical outcomes. METHODS: We analyzed a prospective cohort of subarachnoid hemorrhage patients who underwent dynamic contrast–enhanced magnetic resonance imaging at a median (interquartile range) of 4 (2–6) days after clinical onset. Permeability maps were used to obtain K-trans values as a measure of increased blood-brain barrier permeability in the whole brain, gray matter, and white matter. Circulating neuroinflammatory molecules, including IL (interleukin) 8 and PDGF (platelet-derived growth factor), were measured using Multiplex-ELISA in blood samples collected concurrently with magnetic resonance imaging acquisition. Poor clinical outcome was defined as a modified Rankin Scale score of >2 at 90 days. Associations between K-trans values, neuroinflammatory mediators, and clinical outcomes were assessed using univariate and multivariate regression models. RESULTS: From 153 patients initially screened, 96 were finally included (63% females; median age, 55 years; 43% premorbid hypertension; 32% World Federation of Neurosurgical Societies grade 4–5; 31% poor outcome). In adjusted linear regression analyses, higher K-trans values were significantly associated with increased IL-8 ( P =0.001) and PDGF ( P =0.018) levels. In univariate analysis, K-trans values in white matter were significantly higher in patients with poor clinical outcome (median [interquartile range], 2.5 [2.07–6.09] ×10 −3 ·min −1 ) compared with good clinical outcome (median [interquartile range], 2.0 [1.60–2.42] ×10 −3 ·min −1 ; P <0.001). In models adjusted by age, World Federation of Neurosurgical Societies, hypertension, intraparenchymal hematoma, aneurysm size, and time to magnetic resonance imaging, elevated K-trans values remained independently associated with poor outcome (adjusted odds ratio per interquartile range increase, 3.31 [95% CI, 1.485–7.377]; P =0.003). CONCLUSIONS: Increased blood-brain barrier permeability correlates with circulating neuroinflammatory mediator levels and is associated with poor clinical recovery at 3 months. These findings support the potential role of white matter permeability alterations as both biomarker and therapeutic target in subarachnoid hemorrhage.

1 September 2025 in Stroke
Verified
Journal Article
Open access
CFChiara Faso
Chiara Faso
EBElisa Gouvêa Bogossian
Elisa Gouvêa Bogossian
CRCarla Bittencourt Rynkowski
Carla Bittencourt Rynkowski
KMKirsten Moller
Kirsten Moller
PLPiet Lormans
Piet Lormans
MBMelanie Glasbergen-Van Beijeren
Melanie Glasbergen-Van Beijeren
BACKGROUND: Red blood cell transfusions are commonly administered to anemic patients with spontaneous intracerebral hemorrhage (ICH); however, the optimal hemoglobin threshold to initiate transfusion is uncertain in this population. Therefore, we aimed to assess the impact of 2 different hemoglobin thresholds to guide transfusion on the neurological outcome of anemic critically ill patients with ICH. METHODS: This is a secondary analysis of a prospective, multicenter, phase 3 randomized study conducted in 72 intensive care units across 22 countries from 2017 to 2022. Eligible patients for the original trial had an acute brain injury, hemoglobin values ≤9 g/dL within the first 10 days after admission, and an expected intensive care unit stay of at least 72 hours; in this study, only patients with spontaneous ICH were assessed. Patients were randomly assigned to undergo a restrictive (transfusion triggered by hemoglobin ≤7 g/dL) or a liberal (transfusion triggered by hemoglobin ≤9 g/dL) strategy over a 28-day period. The primary outcome was the occurrence of an unfavorable neurological outcome, defined as a Glasgow Outcome Scale Extended score of 1 to 5, at 180 days following randomization. RESULTS: A total of 144 patients with spontaneous ICH were analyzed: 45.8% of them were men with a mean age of 58.4 (SD, 13.4). Mean Glasgow Coma Scale on admission was 7.3 (SD, 3.3), and 75.7% of patients had a volume of hematoma >30 mL. Among all patients, 73 were randomized to the restrictive transfusion strategy, while 71 to the liberal one. Baseline characteristics were comparable between the 2 groups. At 180 days after randomization, patients assigned to the liberal transfusion strategy had a nonsignificant decrease in the probability of unfavorable neurological outcome (71.8 versus 84.7%; risk ratio, 0.85 [95% CI, 0.71–1.01]; P =0.06). Also, the occurrence of the composite outcome (mortality and organ failure at day 28) was significantly lower in the liberal group (71.8% versus 87.7%, risk ratio, 0.82 [95% CI, 0.69–0.97]; P =0.02). CONCLUSIONS: A liberal transfusion strategy was associated with a lower risk of mortality and organ failure, but not of unfavorable outcome in patients presenting with spontaneous ICH, compared with a restrictive strategy. However, the study cohort might have been underpowered to detect clinically relevant differences between the 2 interventions.

12 July 2024 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
DSDaniel Santana
Daniel Santana
LLLaura Llull
Laura Llull
AMAlejandra Mosteiro
Alejandra Mosteiro
LPLeire Pedrosa
Leire Pedrosa
GPGabriel Pujol
Gabriel Pujol
SASergio Amaro
Sergio Amaro
Hyperglycemia during early brain injury (EBI) period after spontaneous subarachnoid hemorrhage (SAH) is associated with poor outcome, but the underlying physiopathology is unknown. This study assessed if hyperglycemia during EBI is associated with markers of neuroaxonal injury and whether these biomarkers partially account for the association between hyperglycemia and poor clinical outcome. Ninety-two SAH patients admitted within 24 h of bleeding onset were prospectively included. Glucose levels were measured at arrival and every 6 h for 72 h. Serum neurofilament light chain (NFL) levels were measured at 72 h. Functional outcome was assessed with the modified Rankin Scale (mRS) at 90 days (poor outcome, mRS > 2). The association between glucose metrics, NFL levels, and clinical outcome was assessed with univariate and multivariate analyses. Mediation analysis was performed to examine the potential chain in which NFL may mediate the relationship between glucose and functional outcome. Higher glucose and NFL levels during EBI were associated with poor clinical outcome in adjusted analysis. NFL levels were associated with older age, higher initial severity, and higher glucose levels during EBI period. In adjusted mediation analyses, the association between glucose and clinical outcome was significantly mediated by NFL levels. The mediator NFL explained 25% of the association between glucose during EBI period and poor functional outcome at 90 days. In SAH, the association between glucose levels during EBI and poor clinical outcome might be significantly mediated by NFL levels. The link between hyperglycemia and poor clinical outcome might be explained in part through secondary neuroaxonal injury.

19 August 2024 in World Neurosurgery
Verified
Journal Article
Closed access
AMAlejandra Mosteiro
Alejandra Mosteiro
LLLaura Llull
Laura Llull
LPLeire Pedrosa
Leire Pedrosa
SASergio Amaro
Sergio Amaro
LRLuis A. Reyes
Luis A. Reyes
RTRamon Torné
Ramon Torné

5 September 2025 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
ABAdela Benitez-Cano
Adela Benitez-Cano
XLXin Liu
Xin Liu
HXHaiping Xu
Haiping Xu
XTXinyi Tang
Xinyi Tang
LZLuigi Zattera
Luigi Zattera
XZXiao Zhu
Xiao Zhu